Clinical trial Recruiting at 2 sites Interventional Ages 14 Days to 14 Days

Comparing iron supplementation methods in premature babies

Official title: The Benefit in Terms of Improvement in Haemoglobin Level at 6 Months in Premature Babies Receiving Alternate Iron Substitution 4 Times a Week Compared to a Daily Substitution

Run by University Hospital, Geneva · NCT06624709 · Data updated 2026-11-12

This study is testing if giving iron to premature babies four times a week instead of every day can help their blood levels while causing less tummy pain and constipation.

Quick facts

Study typeInterventional
Ages14 Days to 14 Days
SexAll
Enrollment160 (estimated)
SponsorUniversity Hospital, Geneva
Academic / other
Locations2 sites (Geneva, Canton of Geneva and 1 other locations)
StatusRecruiting
StartedNovember 2, 2024
Main results expectedSeptember 16, 2026
Study endsMay 2027
Registry record updatedMay 25, 2025
Trial IDNCT06624709 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are premature babies born between 28 and 34 weeks of gestation who are at least 2 weeks old.

Probably not a fit

Patients with severe anemia, significant congenital disorders, or specific gastrointestinal complications may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of alternate iron supplementation four times a week versus daily iron supplementation in premature infants aged 2 weeks to 6 months. The study aims to determine if the alternate method can improve hemoglobin levels while reducing abdominal pain and constipation, which are common side effects of iron supplementation. By utilizing a double-blinded randomized controlled design, the trial seeks to provide robust data on the efficacy and tolerability of these two approaches to iron supplementation in this vulnerable population.

Why it matters

Potential benefit: If successful, this study could lead to improved iron supplementation practices that enhance the health and development of premature infants.

How similar studies have gone: Previous studies have shown that alternate iron supplementation can improve adherence and reduce side effects, but this specific comparison in premature infants is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Premature babies between 28 0/7WA and 34 6/7 WA
* Parental consent, postnatal
* Age of 2 weeks

Exclusion Criteria:

* anemia \< 80g/l at 2 weeks of age
* Intraventricular Hemorrhage stage III and IV
* Necrotizing Enterocolitis
* Enteral feeding less than 100ml/kg/j after 2 weeks of life
* Congenital disorder

Where it's running

  • Hug
    Geneva, Canton of Geneva, Switzerland
    Recruiting
  • Chuv
    Lausanne, Canton of Vaud, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.